411 related articles for article (PubMed ID: 21659539)
1. CXCL13/CXCR5 signaling enhances BCR-triggered B-cell activation by shaping cell dynamics.
Sáez de Guinoa J; Barrio L; Mellado M; Carrasco YR
Blood; 2011 Aug; 118(6):1560-9. PubMed ID: 21659539
[TBL] [Abstract][Full Text] [Related]
2. Spin90 deficiency increases CXCL13-mediated B cell migration.
Park SH; Kim HR; Jun CD; Song WK; Park SG
Scand J Immunol; 2014 Sep; 80(3):191-7. PubMed ID: 24965518
[TBL] [Abstract][Full Text] [Related]
3. EBI2 regulates CXCL13-mediated responses by heterodimerization with CXCR5.
Barroso R; Martínez Muñoz L; Barrondo S; Vega B; Holgado BL; Lucas P; Baíllo A; Sallés J; Rodríguez-Frade JM; Mellado M
FASEB J; 2012 Dec; 26(12):4841-54. PubMed ID: 22913878
[TBL] [Abstract][Full Text] [Related]
4. LFA-1/ICAM-1 interaction lowers the threshold of B cell activation by facilitating B cell adhesion and synapse formation.
Carrasco YR; Fleire SJ; Cameron T; Dustin ML; Batista FD
Immunity; 2004 May; 20(5):589-99. PubMed ID: 15142527
[TBL] [Abstract][Full Text] [Related]
5. The healing myocardium mobilizes a distinct B-cell subset through a CXCL13-CXCR5-dependent mechanism.
Heinrichs M; Ashour D; Siegel J; Büchner L; Wedekind G; Heinze KG; Arampatzi P; Saliba AE; Cochain C; Hofmann U; Frantz S; Campos Ramos G
Cardiovasc Res; 2021 Nov; 117(13):2664-2676. PubMed ID: 34048536
[TBL] [Abstract][Full Text] [Related]
6. CXCL13 responsiveness but not CXCR5 expression by late transitional B cells initiates splenic white pulp formation.
Neely HR; Flajnik MF
J Immunol; 2015 Mar; 194(6):2616-23. PubMed ID: 25662995
[TBL] [Abstract][Full Text] [Related]
7. The actin and tetraspanin networks organize receptor nanoclusters to regulate B cell receptor-mediated signaling.
Mattila PK; Feest C; Depoil D; Treanor B; Montaner B; Otipoby KL; Carter R; Justement LB; Bruckbauer A; Batista FD
Immunity; 2013 Mar; 38(3):461-74. PubMed ID: 23499492
[TBL] [Abstract][Full Text] [Related]
8. A B-cell actomyosin arc network couples integrin co-stimulation to mechanical force-dependent immune synapse formation.
Wang JC; Yim YI; Wu X; Jaumouille V; Cameron A; Waterman CM; Kehrl JH; Hammer JA
Elife; 2022 Apr; 11():. PubMed ID: 35404237
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of the receptor-ligand pair CXCR5/CXCL13 in B cells during chronic HIV-1 infection.
Cagigi A; Mowafi F; Phuong Dang LV; Tenner-Racz K; Atlas A; Grutzmeier S; Racz P; Chiodi F; Nilsson A
Blood; 2008 Dec; 112(12):4401-10. PubMed ID: 18780835
[TBL] [Abstract][Full Text] [Related]
10. CXC chemokine ligand-13 promotes metastasis via CXCR5-dependent signaling pathway in non-small cell lung cancer.
Chao CC; Lee WF; Wang SW; Chen PC; Yamamoto A; Chang TM; Weng SL; Liu JF
J Cell Mol Med; 2021 Oct; 25(19):9128-9140. PubMed ID: 34427969
[TBL] [Abstract][Full Text] [Related]
11. Cofilin-mediated F-actin severing is regulated by the Rap GTPase and controls the cytoskeletal dynamics that drive lymphocyte spreading and BCR microcluster formation.
Freeman SA; Lei V; Dang-Lawson M; Mizuno K; Roskelley CD; Gold MR
J Immunol; 2011 Dec; 187(11):5887-900. PubMed ID: 22068232
[TBL] [Abstract][Full Text] [Related]
12. CXCR5 is critically involved in progression of lupus through regulation of B cell and double-negative T cell trafficking.
Wiener A; Schippers A; Wagner N; Tacke F; Ostendorf T; Honke N; Tenbrock K; Ohl K
Clin Exp Immunol; 2016 Jul; 185(1):22-32. PubMed ID: 26990531
[TBL] [Abstract][Full Text] [Related]
13. Dynamic cortical actin remodeling by ERM proteins controls BCR microcluster organization and integrity.
Treanor B; Depoil D; Bruckbauer A; Batista FD
J Exp Med; 2011 May; 208(5):1055-68. PubMed ID: 21482698
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia.
Bürkle A; Niedermeier M; Schmitt-Gräff A; Wierda WG; Keating MJ; Burger JA
Blood; 2007 Nov; 110(9):3316-25. PubMed ID: 17652619
[TBL] [Abstract][Full Text] [Related]
15. Actin-binding protein 1 regulates B cell receptor-mediated antigen processing and presentation in response to B cell receptor activation.
Onabajo OO; Seeley MK; Kale A; Qualmann B; Kessels M; Han J; Tan TH; Song W
J Immunol; 2008 May; 180(10):6685-95. PubMed ID: 18453588
[TBL] [Abstract][Full Text] [Related]
16. CXCL13 antibody for the treatment of autoimmune disorders.
Klimatcheva E; Pandina T; Reilly C; Torno S; Bussler H; Scrivens M; Jonason A; Mallow C; Doherty M; Paris M; Smith ES; Zauderer M
BMC Immunol; 2015 Feb; 16(1):6. PubMed ID: 25879435
[TBL] [Abstract][Full Text] [Related]
17. The actin-based motor protein myosin II regulates MHC class II trafficking and BCR-driven antigen presentation.
Vascotto F; Lankar D; Faure-André G; Vargas P; Diaz J; Le Roux D; Yuseff MI; Sibarita JB; Boes M; Raposo G; Mougneau E; Glaichenhaus N; Bonnerot C; Manoury B; Lennon-Duménil AM
J Cell Biol; 2007 Mar; 176(7):1007-19. PubMed ID: 17389233
[TBL] [Abstract][Full Text] [Related]
18. CXCL13 drives spinal astrocyte activation and neuropathic pain via CXCR5.
Jiang BC; Cao DL; Zhang X; Zhang ZJ; He LN; Li CH; Zhang WW; Wu XB; Berta T; Ji RR; Gao YJ
J Clin Invest; 2016 Feb; 126(2):745-61. PubMed ID: 26752644
[TBL] [Abstract][Full Text] [Related]
19. CD23 can negatively regulate B-cell receptor signaling.
Liu C; Richard K; Wiggins M; Zhu X; Conrad DH; Song W
Sci Rep; 2016 May; 6():25629. PubMed ID: 27181049
[TBL] [Abstract][Full Text] [Related]
20. CXCL13/CXCR5 signalling is pivotal to preserve motor neurons in amyotrophic lateral sclerosis.
Trolese MC; Mariani A; Terao M; de Paola M; Fabbrizio P; Sironi F; Kurosaki M; Bonanno S; Marcuzzo S; Bernasconi P; Trojsi F; Aronica E; Bendotti C; Nardo G
EBioMedicine; 2020 Dec; 62():103097. PubMed ID: 33161233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
